Skip to main content
. 2012 Jun 12;35(7):1538–1543. doi: 10.2337/dc11-1513

Figure 1.

Figure 1

Age-adjusted cumulative survival among cancer incident patients by basal insulin. The curves represent the cumulative survival of cancer incident patients over 18 years of follow-up according to baseline basal insulin in the lower three quartiles (Q1-Q3) and the upper quartile (Q4).